Home > Search Results: Bahlis, Nizar
  Search Tips
Advanced Search
Search collections:
Sort by: Display results: Output format:
Results overview: Found 3 records in 0.01 seconds.
Articles, 3 records found
Articles 3 records found  
1.
13 p, 471.4 KB Overall Survival with Daratumumab, Lenalidomide, and Dexamethasone in Previously Treated Multiple Myeloma (POLLUX) : A Randomized, Open-Label, Phase III Trial / Dimopoulos, Meletios (National and Kapodistrian University of Athens) ; Oriol, Albert (Institut Germans Trias i Pujol. Institut de Recerca contra la Leucèmia Josep Carreras) ; Nahi, Hareth (Department of Medicine. Karolinska University) ; San-Miguel, J (Clínica Universidad de Navarra) ; Bahlis, Nizar J. (University of Calgary) ; Usmani, S. Z (Memorial Sloan Kettering Cancer Center) ; Rabin, Neil (Department of Haematology. University College London Hospitals NHS Trust) ; Orlowski, Robert Z. (Department of Lymphoma and Myeloma. The University of Texas) ; Suzuki, Kenshi (Department of Hematology. Japanese Red Cross Medical Center) ; Plesner, Torben (University of Southern Denmark) ; Yoon, Sung Soo (Department of Internal Medicine. Seoul National University) ; Ben Yehuda, Dina (Hematology Department. Hebrew University) ; Richardson, Paul G. (Dana-Farber Cancer Institute (Estats Units d'Amèrica)) ; Goldschmidt, Hartmut (Heidelberg University Hospital (Alemanya)) ; Reece, Donna (Department of Medical Oncology and Hematology. Princess Margaret Cancer Centre) ; Ahmadi, Tahamtan (Genmab US (Estats Units d'Amèrica)) ; Qin, Xiang (Janssen Research & Development (Xina)) ; Garvin Mayo, Wendy (Janssen Research & Development (Estats Units d'Amèrica)) ; Gai, Xue (Janssen Research & Development (Estats Units d'Amèrica)) ; Carey, Jodi (Janssen Research & Development (Estats Units d'Amèrica)) ; Carson, Robin (Janssen Research & Development (Estats Units d'Amèrica)) ; Moreau, Philippe (Hematology Department. University Hospital Hôtel-Dieu)
PURPOSEWith the initial analysis of POLLUX at a median follow-up of 13. 5 months, daratumumab in combination with lenalidomide and dexamethasone (D-Rd) significantly prolonged progression-free survival versus lenalidomide and dexamethasone (Rd) alone in patients with relapsed or refractory multiple myeloma (RRMM). [...]
2023 - 10.1200/JCO.22.00940
Journal of Clinical Oncology, Vol. 41 Núm. 8 (october 2023) , p. 1590-1599  
Detailed record - Creative Commons
2.
9 p, 603.3 KB Teclistamab Improves Patient-Reported Symptoms and Health-Related Quality of Life in Relapsed or Refractory Multiple Myeloma : Results From the Phase II MajesTEC-1 Study / Martin, Thomas G. (University of California San Francisco, USA) ; Moreau, Philippe (University Hospital Hôtel-Dieu, Nantes, France) ; Usmani, Saad Z. (Levine Cancer Institute/Atrium Health, Charlotte, NC) ; Garfall, Alfred (University of Pennsylvania, Philadelphia, PA) ; Mateos, M. V (Hospital Universitario de Salamanca) ; San-Miguel, Jesús F. (Clínica Universidad de Navarra) ; Oriol, Albert (Institut Germans Trias i Pujol. Institut de Recerca contra la Leucèmia Josep Carreras) ; Nooka, Ajay K. (Emory University, Atlanta, GA) ; Rosiñol, Laura (Hospital Clínic i Provincial de Barcelona) ; Chari, Ajay (Mount Sinai School of Medicine, New York, USA) ; Karlin, Lionel (Centre Hospitalier Lyon Sud, Pierre-Bénite, France) ; Krishnan, Amrita (City of Hope National Medical Center (Duarte, Estats Units d'Amèrica)) ; Bahlis, Nizar (University of Calgary, Canada) ; Popat, Rakesh (University College London) ; Besemer, Britta (University of Tuebingen, Tuebingen, Germany) ; Martínez-López, Joaquín (Hospital Universitario 12 de Octubre (Madrid)) ; Delforge, Michel (Universitaire Ziekenhuizen Leuven, Belgium) ; Trancucci, Danielle (Janssen Research & Development, Raritan, NJ) ; Pei, Lixia (Janssen Research & Development, Raritan, NJ) ; Kobos, Rachel (Janssen Research & Development, Raritan, NJ) ; Fastenau, John (Janssen Research & Development, Raritan, NJ) ; Gries, Katharine S. (Janssen Research & Development, Raritan, NJ) ; van de Donk, Niels W.C.J. (Amsterdam University Medical Center, Vrije Universiteit Amsterdam, The Netherlands)
Introduction: Patients with relapsed or refractory multiple myeloma (RRMM) report significantly lower HRQoL compared with patients with newly diagnosed MM and experience further deterioration in HRQoL with each relapse and subsequent treatment. [...]
2023 - 10.1016/j.clml.2023.11.001
Clinical Lymphoma, Myeloma & Leukemia, 2023  
Detailed record - Creative Commons
3.
8 p, 2.0 MB Benefit of continuous treatment for responders with newly diagnosed multiple myeloma in the randomized FIRST trial / Bahlis, Nizar J (University of Calgary) ; Corso, A. (Policlinico San Matteo Universita di Pavia) ; Mugge, L.O. (Universitätsklinikum Jena Klinik für Innere Medizin II) ; Shen, Z.X. (Shanghai Jiao Tong University) ; Desjardins, Pierre (Hôpital Charles LeMoyne) ; Stoppa, A.M. (Institut Paoli Calmettes) ; Decaux, O. (CHRU Hôpital Sud Médecine Interne) ; De Revel, T. (Hôpital d'Instruction des Armées PERCY) ; Granell, Miquel (Institut d'Investigació Biomèdica Sant Pau) ; Marit, G. (CHU de Bordeaux) ; Nahi, H. (Karolinska Institutet (Suecia)) ; Demuynck, H. (H. Hart Ziekenhuis Roeselare-Menen) ; Huang, S.Y. (National Taiwan University Hospital (Taipei, Taiwan)) ; Basu, S. (New Cross Hospital) ; Guthrie, T.H. (21st Century Oncology) ; Ervin-Haynes, A. (Celgene Corporation) ; Marek, J. (Celgene Corporation) ; Chen, G. (Celgene Corporation) ; Facon, T. (CHRU Lille) ; Universitat Autònoma de Barcelona
The phase 3, randomized Frontline Investigation of Revlimid and Dexamethasone Versus Standard Thalidomide (FIRST) trial investigating lenalidomide plus low-dose dexamethasone until disease progression (Rd continuous) vs melphalan, prednisone and thalidomide for 12 cycles (MPT) and Rd for 18 cycles (Rd18) in transplant-ineligible patients with newly diagnosed multiple myeloma (NDMM) showed that Rd continuous prolonged progression-free survival and overall survival compared with MPT. [...]
2017 - 10.1038/leu.2017.111
Leukemia, Vol. 31 Núm. 11 (january 2017) , p. 2435-2442  
Detailed record - Creative Commons

See also: similar author names
1 Bahlis, N. J.
1 Bahlis, Nizar J
1 Bahlis, Nizar J.
Interested in being notified about new results for this query?
Set up a personal email alert or subscribe to the RSS feed.
UAB Digital Repository of Documents :: Search :: Submit :: Personalize :: Help
Powered by Invenio v1.1.6
Maintained by ddd.bib@uab.cat  :: Metadata license:
Working with